Get the latest research updates from investigators across MSK on why so many young adults are getting cancers.

Our group, the Laboratory of Experimental Cancer Immunogenomics, is a multi-disciplinary team of cancer scientists working at the intersection of genomics, molecular genetics, animal modeling, and ...

I am a neurosurgeon and scientist interested in the immunobiology and treatment of brain tumors, including tumors that have arisen from the brain (primary tumors) and tumors that have spread to the ...

Molecular Pharmacology Program Member David Scheinberg focuses on the discovery and development of novel, specific immunotherapeutic agents and targeted nanodevices for cancer therapy.

I am a board-certified radiation oncologist with an expertise in treating primary genitourinary (prostate, bladder, kidney, and testicular) and head and neck (oral cavity, base of tongue, tonsil, ...

Dr. Yueming Li studies disease mechanism of Cancer and Alzheimer’s, with the goal of developing novel therapeutics for clinical use.

Pharmacologist Neal Rosen focuses on understanding biochemical mechanisms underlying phenotypes caused by tyrosine kinase activation in epithelial tumors and developing new therapeutic strategies.

View the Naama Aviram Lab page for Evolution of Immunity Across Domains of Life.